BioNTech SE (BNTX)
100.60
+1.85
(+1.87%)
USD |
NASDAQ |
May 31, 16:00
100.51
-0.09
(-0.09%)
After-Hours: 20:00
BioNTech Accounts Payable (Quarterly): 322.67M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 322.67M |
December 31, 2023 | 391.31M |
September 30, 2023 | 235.73M |
June 30, 2023 | 248.43M |
March 31, 2023 | 32.60M |
December 31, 2022 | 218.88M |
September 30, 2022 | 291.43M |
June 30, 2022 | 304.08M |
March 31, 2022 | 138.06M |
December 31, 2021 | 181.16M |
September 30, 2021 | 300.30M |
Date | Value |
---|---|
June 30, 2021 | 312.62M |
March 31, 2021 | 124.50M |
December 31, 2020 | 125.82M |
September 30, 2020 | 49.21M |
June 30, 2020 | 40.14M |
March 31, 2020 | 21.42M |
December 31, 2019 | 22.96M |
September 30, 2019 | 23.87M |
June 30, 2019 | 19.19M |
December 31, 2018 | 47.72M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
19.19M
Minimum
Jun 2019
391.31M
Maximum
Dec 2023
170.22M
Average
159.61M
Median
Accounts Payable (Quarterly) Benchmarks
Pfizer Inc | 5.591B |
Moderna Inc | 183.00M |
GSK PLC | 18.46B |
NuCana PLC | 7.277M |
Autolus Therapeutics PLC | 1.399M |